Bronchiectasis: Evaluation of an Educational Intervention

Bronchiectasis Clinical Trial

Official title:

Identification of Patients With a Diagnosis of Bronchiectasis: Evaluation of an Educational Intervention

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01315626
• Other study ID #: CR-2010-04
• Status: Withdrawn
• Phase: N/A
• First received: December 20, 2010
• Last updated: March 17, 2015
• Start date: January 2011
• Est. completion date: February 2011

Study information

• Verified date: March 2011
• Source: Hill-Rom
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

A study of an educational intervention of primary care practice physicians to assist in the identification of patients who have Bronchiectasis and to assess the effectiveness of the specific didactic educational intervention targeting primary care physicians in the recognition of Bronchiectasis.

Description:

A pilot study will be conducted for the purpose of evaluating an educational intervention (Description in Appendix A). As part of the educational intervention, primary care physician(s) will be trained in the use of an algorithm to guide assessment of patients seen with a respiratory chief complaint, and who have not previously been identified as having a diagnosis of BE. We propose an evaluation of three primary care practice(s) to compare the number of patients identified in three three-month periods as having a diagnosis of BE.

The evaluation periods will be as follows: Period 1) the three-month period immediately following the intervention, Period 2) the three-month period immediately preceding the intervention, Period 3) the three month period starting one year prior to the intervention.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: February 2011
• Est. primary completion date: February 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Respiratory is the chief complaint

2. Patient > 35 years of age

3. Seen in practice for > 12 months

Exclusion Criteria:

1) Prior diagnosis with bronchiectasis

Study Design

Time Perspective: Retrospective

Related Conditions & MeSH terms

• Bronchiectasis

Intervention

Other:
• Primary Care Educational event
The purpose of this study is to assess the accuracy of primary care physicians in diagnosing BE and evaluate the impact of an educational intervention targeting those primary care physicians and providing instruction in the recognition and treatment of BE. The hope is that a better understanding of the disease will result in more accurate diagnoses and ultimately in more appropriate care for these patients. In addition to better care for patients, earlier recognition of bronchiectasis may result in a decrease in health care costs.

Locations

Country	Name	City	State
United States	Howard Rupard, MD Primary Care Practice	Shelbyville	Tennessee

Sponsors (1)

Lead Sponsor	Collaborator
Hill-Rom

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number / Percent of BE patients	The primary outcome for this study will be the number/proportion of patients that meet entrance criteria that are subsequently diagnosed with bronchiectasis.	18 months	No
Secondary	HRCT patients	Secondary outcomes are the number/proportion of those subjects that undergo HRCT, and the number/proportion of subjects that are then identified as having Bronchiectasis.	18 months	No